Live
- Opposition Slams ‘One Nation, One Election’ Bill as Anti-Democratic; BJP Allies Support the Move
- Celebrate Karthigai Maha Deepam Virtually with Sri Mandir’s LIVE Darshan Experience
- BJP Extends Support to Samagra Shiksha Abhiyan Employees' Strike, Demands Immediate Regularization and Welfare Benefits
- Dr. M. Priyanka Stresses Quality Education, Nutritious Meals, and Cleanliness in Schools
- Mandal Level CM Cup Sports Concludes in Ija with Promising Talent and Enthusiastic Participation
- Harish Rao Slams Revanth Reddy: "More Talk, Less Action"
- Revolutionising Oil and Gas: Gaurav Kumar Sinha’s AI-Driven Innovations Transforming Efficiency and Profitability
- AiDASH Names Vishal Jain Head of AI to Advance First Integrated Platform for Grid Inspection and Monitoring
- Congress Central Election Committee has finalised the names of around 20 candidates for the upcoming Delhi Assembly elections
- District Collector Adarsh ​​Surabhi has ordered to expedite the land acquisition process related to irrigation projects in the district
DRDO to release wonder drug 2DG today
New Delhi: The Defence Research and Development Organisation's anti-Covid drug will be made available next week to those who are in need, bringing in...
New Delhi: The Defence Research and Development Organisation's anti-Covid drug will be made available next week to those who are in need, bringing in a major relief to thousands of people who are struggling for breath undergoing treatment in hospitals.
Speaking to The Hans India, Dr Satish Reddy, Secretary, Department of Defence Research and Development and Chairman, DRDO, informed that the new drug -2-deoxy-D-glucose (2DG)- that was developed by a defence lab of the DRDO will be released either on Tuesday or Wednesday.
He said sachets of the new anti-Covid drug will be available in sizable numbers after three weeks. He said large-scale production of the drug is in the offing.
As far as the efficacy of the drug is concerned in view of the new Covid strains emerged during the second wave, Dr Sateesh Reddy said the drug can deal with any virus strain. This assumes importance since the trials on this new drug were made during the first wave of Covid-19.
According to Dr Reddy, the drug had proved to be very effective as 51 percent of the patients were cured within three days during the third phase of clinical trials and others in about 5 to 7 days of administering the drug. This new drug can be used for moderate to severe Covid patients, he said.
"2-DG accumulates in the virus-infected cells and prevents virus growth by stopping viral synthesis and energy production. Its selective accumulation in virally infected cells makes this drug unique," Dr Reddy maintained.
